Olanzapine versus Ziprasidone: Quality-of-life changes in patients with schizophrenia

被引：0
|
作者：
Namioshi, M
Xu, W
Berg, PH
Roychowdhury, SM
Cavazzoni, P
Naber, D
Breier, A
机构：
[1] Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Indianapolis, IN 46285 USA
[2] Univ Hamburg, Hamburg, Germany
来源：
JOURNAL OF PSYCHOPHARMACOLOGY | 2003年 / 17卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A50 / A50
页数：1
相关论文
共 50 条
  • [1] Quality of Life and Adverse Effects of Olanzapine Versus Risperidone Therapy in Patients with Schizophrenia
    Chaves, Katarina Melo
    Serrano-Blanco, Antoni
    Ribeiro, Susana Barbosa
    Lira Soares, Luiz Alberto
    Bernardo Guerra, Gerlane Coelho
    Costa Feitosa Alves, Maria do Socorro
    de Araujo Junior, Raimundo Fernandes
    Soares Rachetti, Vanessa de Paula
    Filgueira Junior, Antonio
    de Araujo, Aurigena Antunes
    PSYCHIATRIC QUARTERLY, 2013, 84 (01) : 125 - 135
  • [2] The effectiveness of olanzapine versus placebo in maintaining the Quality of Life in stabilized patients with schizophrenia
    Beasley, CM
    Walker, DJ
    Sutton, VK
    Alaka, K
    Naber, D
    Namjoshi, M
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 : S342 - S343
  • [3] Olanzapine versus ziprasidone in parenteral administration in psychotic relapse of schizophrenia
    Tudor, C.
    Ungureanu, D.
    Gheorghe, M. D.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2006, 16 : S397 - S398
  • [4] Quality of Life and Adverse Effects of Olanzapine Versus Risperidone Therapy in Patients with Schizophrenia
    Katarina Melo Chaves
    Antoni Serrano-Blanco
    Susana Barbosa Ribeiro
    Luiz Alberto Lira Soares
    Gerlane Coelho Bernardo Guerra
    Maria do Socorro Costa Feitosa Alves
    Raimundo Fernandes de Araújo Júnior
    Vanessa de Paula Soares Rachetti
    Antônio Filgueira Júnior
    Aurigena Antunes de Araújo
    Psychiatric Quarterly, 2013, 84 : 125 - 135
  • [5] Improvement of comorbid depression with olanzapine versus ziprasidone treatment in patients with schizophrenia or schizoaffective disorder
    Kinon, BJ
    Lipkovich, I
    Edwards, SE
    Hill, AL
    Tollefson, GD
    BIOLOGICAL PSYCHIATRY, 2004, 55 : 185S - 186S
  • [6] Improvement of comorbid depression with olanzapine versus ziprasidone treatment in patients with schizophrenia or schizoaffective disorder
    Kinon, BJ
    Lipkovich, I
    Edwards, SE
    SCHIZOPHRENIA BULLETIN, 2005, 31 (02) : 491 - 491
  • [7] Improvement of comorbid depression with olanzapine versus ziprasidone treatment in patients with schizophrenia or schizoaffective disorder
    Kinon, B
    Lipkovich, I
    Edwards, S
    Hill, A
    Ahl, J
    SCHIZOPHRENIA RESEARCH, 2004, 67 (01) : 163 - 163
  • [8] Ziprasidone versus olanzapine in schizophrenia: Six-month continuation study
    Simpson, GM
    Weiden, P
    Pigott, T
    Romano, SJ
    Siu, C
    SCHIZOPHRENIA RESEARCH, 2003, 60 (01) : 303 - 303
  • [9] Comparison of metabolic effects of ziprasidone versus olanzapine treatment in patients with first-episode schizophrenia
    Ou, Jian-Jun
    Xu, Yi
    Chen, Hong-Hui
    Fan, Xiaoduo
    Gao, Keming
    Wang, Juan
    Guo, Xiao-Feng
    Wu, Ren-Rong
    Zhao, Jing-Ping
    PSYCHOPHARMACOLOGY, 2013, 225 (03) : 627 - 635
  • [10] Comparison of metabolic effects of ziprasidone versus olanzapine treatment in patients with first-episode schizophrenia
    Jian-Jun Ou
    Yi Xu
    Hong-Hui Chen
    Xiaoduo Fan
    Keming Gao
    Juan Wang
    Xiao-Feng Guo
    Ren-Rong Wu
    Jing-Ping Zhao
    Psychopharmacology, 2013, 225 : 627 - 635
12345